Baird Initiates Coverage On Qiagen with Outperform Rating, Announces Price Target of $50
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Catherine Schulte has initiated coverage on Qiagen (NYSE:QGEN) with an Outperform rating and a price target of $50.
September 12, 2023 | 8:37 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Qiagen has received an Outperform rating from Baird with a price target of $50, indicating positive expectations for the stock.
The Outperform rating from Baird indicates that the analyst expects Qiagen to do better than the market average or its peers. The price target of $50 suggests that the analyst believes there is significant upside potential for the stock. This could lead to increased investor interest and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100